Projects / 院外研究計畫

2025.08 ∼ 2028.07, PI, NSTC 114-2628-B-075B-001-MY3 (優秀年輕學者研究計畫)
Targeting Mitochondrial Transfer as a Strategy to Prevent Cellular Senescence.

2025.08 ∼ 2028.07, Co-PI, NSTC 114-2314-B-075B-004-MY3
Mechanistic Insights into Ovarian Aging: The Impact of NADK2 Deficiency on Mitochondrial Dysfunction.

2025.08 ∼ 2026.07, Co-PI, NSTC 114-2314-B-075B-013
Exploring SHMT2 as a Metabolic Driver of Breast Cancer Metastasis and Therapeutic Target.

2024.01 ∼ 2024.12, PI, KSVGH113-061
Integrative Analysis of Mitochondrial ATP Transporter in Breast Cancer .

2023.08 ∼ 2024.07, Co-PI, NSTC 112-2314-B-075B-020
ALKBH1 as a Key Player in the Tumor Microenvironment of Gastric Cancer: Insights from Multi-Omics Analysis.

2023.08 ∼ 2024.07, Co-PI, NSTC 112-2314-B-075B-008
The role of oxidative phosphorylation in epithelial-mesenchymal transition of breast cancer.

2022.08 ∼ 2025.07, PI, MOST 111-2314-B-075B-004-MY3
Preclinical development of metabolic reprogramming as a therapeutic strategy in ovarian aging.

2022.08 ∼ 2025.07, Co-PI, MOST 111-2314-B-075B-014-MY3
Preclinical research of targeting PGAM5 in female reproductive system during aging.

2021.01 ∼ 2023.12, PI, KSVGH112-147
The crosstalk between metabolic shift and tumor metastasis in the development of breast cancer.

2022.01 ∼ 2022.12, PI, 111-G6-2-2 (VGHUST Joint Research Program)
Deciphering the interplay among breast cancer metastasis and energy carrier protein: a multi-omics approach.

2022.01 ∼ 2022.12, PI, CI-111-16 (Yen Tjing Ling Medical Foundation)
Bioenergetic crosstalk between young and aged granulosa cells through the intercellular trafficking of mitochondria.

2021.08 ∼ 2022.07, PI, MOST 110-2314-B-075B-011
The role of mitochondrial ATP synthase: metabolic adaptation and progression of breast cancer.

2021.08 ∼ 2022.07, Co-PI, MOST 110-2314-B-075B-006
Preclinical research of targeting PGAM5 in female reproductive system during aging.

2020.08 ∼ 2022.07, Co-PI, MOST 109-2314-B-075B-014 -MY2
The role of energy metabolism in the female mammalian reproductive system.

2020.08 ∼ 2021.07, PI, MOST 109-2314-B-075B-002
Preclinical research of targeting energy metabolism in metastatic breast cancer.

2020.08 ∼ 2021.07, Co-PI, MOST 109-2314-B-442-001
Explore the molecular mechanism of triple negative breast cancer based on tumor bioenergetics.